Actively Recruiting
Study of Heart Complications in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-09-25
400
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating cardiovascular complications in patients undergoing allogeneic hematopoietic stem cell transplantation HSCT for malignant blood diseases. This study focuses on understanding the causes and identifying predictors of heart-related problems such as acute coronary syndrome, heart dysfunction, arrhythmias, pulmonary hypertension, and pericardial effusion that may occur after HSCT. The role of the cardiodepressor factor DPP3 in these complications will be evaluated, as current knowledge about cardiotoxicity in HSCT patients is limited. Participants are patients receiving allogeneic HSCT who will be observed to gather information on heart health using imaging methods including echocardiography, calcium scoring, and supra-aortic Doppler, along with electrocardiographic and biological tests including DPP3 measurement. This observational study will collect data from a cohort of consecutive HSCT patients across multiple centers to improve understanding of cardiotoxicity mechanisms and prognosis. During the one-year follow-up period, participants will undergo evaluations to measure a combined cardiotoxicity outcome including cardiovascular death, heart dysfunction, acute coronary syndrome, pericarditis, and heart rhythm disturbances. The study will monitor imaging, biomarker levels, and heart function to assess cardiovascular risk and outcomes. This information aims to improve cardiological monitoring and management for HSCT recipients over the long term.
CONDITIONS
Brief Title
Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Research Team
T
Trecy Dr Gonçalves, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here